Fixed-ratio combination therapy with GLP-1 receptor agonist liraglutide and insulin degludec in people with type 2 diabetes

Ostergaard, L; Frandsen, CS; Dejgaard, TF; Madsbad, S

Madsbad, S (reprint author), Univ Copenhagen, Hvidovre Hosp, Dept Endocrinol, Copenhagen, Denmark.

EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2017; 10 (6): 621